Erratum: Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer (Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer (2014) 158(1) (185–197), (S0092867414007247), (10.1016/j.cell.2014.06.003));Yap1 activation enables bypass of oncogenic KRAS addiction in pancreatic cancer

Cell

Volumn 158, Issue 1, 2014, Pages 185-197

  Kapoor, Avnish ^a   Yao, Wantong ^a   Ying, Haoqiang ^a   Hua, Sujun ^a   Liewen, Alison ^a   Wang, Qiuyun ^a   Zhong, Yi ^a   Wu, Chang Jiun ^a   Sadanandam, Anguraj ^b,c   Hu, Baoli ^a   Chang, Qing ^a   Chu, Gerald C ^d   Al Khalil, Ramsey ^a   Jiang, Shan ^a   Xia, Hongai ^a   Fletcher Sananikone, Eliot ^a   Lim, Carol ^a   Horwitz, Gillian I ^a   Viale, Andrea ^a   Pettazzoni, Piergiorgio ^a   Sanchez, Nora ^a   Wang, Huamin ^a   Protopopov, Alexei ^a   Zhang, Jianhua ^a   Heffernan, Timothy ^a   Johnson, Randy L ^a   Chin, Lynda ^a   Wang, Y Alan ^a   Draetta, Giulio ^a   Depinho, Ronald A ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c EPFL   (Switzerland)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR YAP1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; CELL CYCLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA REPLICATION; MOUSE; MUTATION; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DNA REPLICATION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; HUMANS; MICE; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS; TRANSCRIPTION FACTORS;

EID: 84903984143     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2019.10.037     Document Type: Erratum

References (57)

1. P.D. Adams, and W.G. Kaelin Jr. The cellular effects of E2F overexpression Curr. Top. Microbiol. Immunol. 208 1996 79 93
2. A.J. Aguirre, N. Bardeesy, M. Sinha, L. Lopez, D.A. Tuveson, J. Horner, M.S. Redston, and R.A. DePinho Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma Genes Dev. 17 2003 3112 3126
3. N. Bardeesy, A.J. Aguirre, G.C. Chu, K.H. Cheng, L.V. Lopez, A.F. Hezel, B. Feng, C. Brennan, R. Weissleder, and U. Mahmood et al. Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse Proc. Natl. Acad. Sci. USA 103 2006 5947 5952
4. K. Berns, and R. Bernards Understanding resistance to targeted cancer drugs through loss of function genetic screens Drug Resist. Updat. 15 2012 268 275
5. A.V. Biankin, N. Waddell, K.S. Kassahn, M.C. Gingras, L.B. Muthuswamy, A.L. Johns, D.K. Miller, P.J. Wilson, A.M. Patch, J. Wu Australian Pancreatic Cancer Genome Initiative Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes Nature 491 2012 399 405
6. P.J. Campbell, S. Yachida, L.J. Mudie, P.J. Stephens, E.D. Pleasance, L.A. Stebbings, L.A. Morsberger, C. Latimer, S. McLaren, and M.L. Lin et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer Nature 467 2010 1109 1113
7. X. Cao, S.L. Pfaff, and F.H. Gage YAP regulates neural progenitor cell number via the TEA domain transcription factor Genes Dev. 22 2008 3320 3334
8. M.A. Collins, F. Bednar, Y. Zhang, J.C. Brisset, S. Galbán, C.J. Galbán, S. Rakshit, K.S. Flannagan, N.V. Adsay, and M. Pasca di Magliano Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice J. Clin. Invest. 122 2012 639 653
9. E.A. Collisson, A. Sadanandam, P. Olson, W.J. Gibb, M. Truitt, S. Gu, J. Cooc, J. Weinkle, G.E. Kim, and L. Jakkula et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Nat. Med. 17 2011 500 503
10. E.A. Collisson, C.L. Trejo, J.M. Silva, S. Gu, J.E. Korkola, L.M. Heiser, R.P. Charles, B.A. Rabinovich, B. Hann, and D. Dankort et al. A central role for RAF→MEK→ERK signaling in the genesis of pancreatic ductal adenocarcinoma Cancer Discov. 2 2012 685 693
11. S. Eser, N. Reiff, M. Messer, B. Seidler, K. Gottschalk, M. Dobler, M. Hieber, A. Arbeiter, S. Klein, and B. Kong et al. Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer Cancer Cell 23 2013 406 420
12. A. Fernandez-L, P.A. Northcott, J. Dalton, C. Fraga, D. Ellison, S. Angers, M.D. Taylor, and A.M. Kenney YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation Genes Dev. 23 2009 2729 2741
13. T. Gao, D. Zhou, C. Yang, T. Singh, A. Penzo-Méndez, R. Maddipati, A. Tzatsos, N. Bardeesy, J. Avruch, and B.Z. Stanger Hippo signaling regulates differentiation and maintenance in the exocrine pancreas Gastroenterology 144 2013 1543 1553
14. N.M. George, C.E. Day, B.P. Boerner, R.L. Johnson, and N.E. Sarvetnick Hippo signaling regulates pancreas development through inactivation of Yap Mol. Cell. Biol. 32 2012 5116 5128
15. C. Guerra, and M. Barbacid Genetically engineered mouse models of pancreatic adenocarcinoma Mol. Oncol. 7 2013 232 247
16. C. Guerra, N. Mijimolle, A. Dhawahir, P. Dubus, M. Barradas, M. Serrano, V. Campuzano, and M. Barbacid Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context Cancer Cell 4 2003 111 120
17. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
18. K.F. Harvey, X. Zhang, and D.M. Thomas The Hippo pathway and human cancer Nat. Rev. Cancer 13 2013 246 257
19. A.F. Hezel, A.C. Kimmelman, B.Z. Stanger, N. Bardeesy, and R.A. Depinho Genetics and biology of pancreatic ductal adenocarcinoma Genes Dev. 20 2006 1218 1249
20. M. Hidalgo Pancreatic cancer N. Engl. J. Med. 362 2010 1605 1617
21. R. Hill, J.H. Calvopina, C. Kim, Y. Wang, D.W. Dawson, T.R. Donahue, S. Dry, and H. Wu PTEN loss accelerates KrasG12D-induced pancreatic cancer development Cancer Res. 70 2010 7114 7124
22. S.R. Hingorani, E.F. Petricoin, A. Maitra, V. Rajapakse, C. King, M.A. Jacobetz, S. Ross, T.P. Conrads, T.D. Veenstra, and B.A. Hitt et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 2003 437 450
23. S. Jones, X. Zhang, D.W. Parsons, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, and A. Jimeno et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
24. J.O. Lauchle, D. Kim, D.T. Le, K. Akagi, M. Crone, K. Krisman, K. Warner, J.M. Bonifas, Q. Li, and K.M. Coakley et al. Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras Nature 461 2009 411 414
25. Y. Liu-Chittenden, B. Huang, J.S. Shim, Q. Chen, S.J. Lee, R.A. Anders, J.O. Liu, and D. Pan Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP Genes Dev. 26 2012 1300 1305
26. F. McCormick Cancer therapy based on oncogene addiction J. Surg. Oncol. 103 2011 464 467
27. J. Moffat, D.A. Grueneberg, X. Yang, S.Y. Kim, A.M. Kloepfer, G. Hinkle, B. Piqani, T.M. Eisenhaure, B. Luo, and J.K. Grenier et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen Cell 124 2006 1283 1298
28. T. Muramatsu, I. Imoto, T. Matsui, K. Kozaki, S. Haruki, M. Sudol, Y. Shimada, H. Tsuda, T. Kawano, and J. Inazawa YAP is a candidate oncogene for esophageal squamous cell carcinoma Carcinogenesis 32 2011 389 398
29. B.N. Nicolay, B. Bayarmagnai, A.B. Islam, N. Lopez-Bigas, and M.V. Frolov Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit Genes Dev. 25 2011 323 335
30. M. Ota, and H. Sasaki Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling Development 135 2008 4059 4069
31. A.V. Pobbati, and W. Hong Emerging roles of TEAD transcription factors and its coactivators in cancers Cancer Biol. Ther. 14 2013 390 398
32. Y. Pylayeva-Gupta, E. Grabocka, and D. Bar-Sagi RAS oncogenes: weaving a tumorigenic web Nat. Rev. Cancer 11 2011 761 774
33. K. Schlegelmilch, M. Mohseni, O. Kirak, J. Pruszak, J.R. Rodriguez, D. Zhou, B.T. Kreger, V. Vasioukhin, J. Avruch, T.R. Brummelkamp, and F.D. Camargo Yap1 acts downstream of α-catenin to control epidermal proliferation Cell 144 2011 782 795
34. D.D. Shao, W. Xue, E.B. Krall, A. Bhutkar, F. Piccioni, X. Wang, A.C. Schinzel, S. Sood, J. Rosenbluh, and J.W. Kim et al. KRAS and YAP1 converge to regulate EMT and tumor survival Cell 157 2014 171 184 this issue
35. A. Singh, P. Greninger, D. Rhodes, L. Koopman, S. Violette, N. Bardeesy, and J. Settleman A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival Cancer Cell 15 2009 489 500
36. A.M. Snijders, B.L. Schmidt, J. Fridlyand, N. Dekker, D. Pinkel, R.C. Jordan, and D.G. Albertson Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma Oncogene 24 2005 4232 4242
37. B.Z. Stanger Quit your YAPing: a new target for cancer therapy Genes Dev. 26 2012 1263 1267
38. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550
39. C. Tamm, N. Böwer, and C. Annerén Regulation of mouse embryonic stem cell self-renewal by a Yes-YAP-TEAD2 signaling pathway downstream of LIF J. Cell Sci. 124 2011 1136 1144
40. D. Torti, and L. Trusolino Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils EMBO Mol. Med. 3 2011 623 636
41. D.A. Tuveson, A.T. Shaw, N.A. Willis, D.P. Silver, E.L. Jackson, S. Chang, K.L. Mercer, R. Grochow, H. Hock, and D. Crowley et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects Cancer Cell 5 2004 375 387
42. A. Vincent, J. Herman, R. Schulick, R.H. Hruban, and M. Goggins Pancreatic cancer Lancet 378 2011 607 620
43. A. von Gise, Z. Lin, K. Schlegelmilch, L.B. Honor, G.M. Pan, J.N. Buck, Q. Ma, T. Ishiwata, B. Zhou, F.D. Camargo, and W.T. Pu YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy Proc. Natl. Acad. Sci. USA 109 2012 2394 2399
44. I.B. Weinstein Cancer. Addiction to oncogenes - the Achilles heal of cancer Science 297 2002 63 64
45. M. Xin, Y. Kim, L.B. Sutherland, M. Murakami, X. Qi, J. McAnally, E.R. Porrello, A.I. Mahmoud, W. Tan, and J.M. Shelton et al. Hippo pathway effector Yap promotes cardiac regeneration Proc. Natl. Acad. Sci. USA 110 2013 13839 13844
46. H. Ying, A.C. Kimmelman, C.A. Lyssiotis, S. Hua, G.C. Chu, E. Fletcher-Sananikone, J.W. Locasale, J. Son, H. Zhang, and J.L. Coloff et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism Cell 149 2012 656 670
47. L. Zender, M.S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, J. Silke, S.T. Fan, J.M. Luk, M. Wigler, and G.J. Hannon et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267
48. H. Zhang, H.A. Pasolli, and E. Fuchs Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin Proc. Natl. Acad. Sci. USA 108 2011 2270 2275
49. B. Zhao, X. Wei, W. Li, R.S. Udan, Q. Yang, J. Kim, J. Xie, T. Ikenoue, J. Yu, and L. Li et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev. 21 2007 2747 2761
50. B. Zhao, X. Ye, J. Yu, L. Li, W. Li, S. Li, J. Yu, J.D. Lin, C.Y. Wang, and A.M. Chinnaiyan et al. TEAD mediates YAP-dependent gene induction and growth control Genes Dev. 22 2008 1962 1971
51. B. Zhao, K. Tumaneng, and K.L. Guan The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal Nat. Cell Biol. 13 2011 877 883
52. M.B. Eisen, P.T. Spellman, P.O. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proc. Natl. Acad. Sci. USA 95 1998 14863 14868
53. R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, and J. Gentry et al. Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 5 2004 R80
54. S.M. Kielbasa, H. Klein, H.G. Roider, M. Vingron, and N. Bluthgen TransFind - predicting transcriptional regulators for gene sets Nucleic Acids Res. 38 2010 W275 W280
55. A.J. Saldanha Java Treeview - extensible visualization of microarray data Bioinformatics 20 2004 3246 3248
56. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat. Appl. Genet. Mol. Biol. 3 2004 Article3
57. H. Zheng, H. Ying, H. Yan, A.C. Kimmelman, D.J. Hiller, A.J. Chen, S.R. Perry, G. Tonon, G.C. Chu, and Z. Ding et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation Nature 455 2008 1129 1133